Return to CG147 Overview

Lower limb peripheral arterial disease: diagnosis and management [CG147]

Measuring the use of this guidance

Recommendation: 1.2.1

Offer all people with peripheral arterial disease information, advice, support and treatment regarding the secondary prevention of cardiovascular disease, in line with published NICE guidance (see Related NICE guidance; section 6) on: • smoking cessation • diet, weight management and exercise • lipid modification and statin therapy • the prevention, diagnosis and management of diabetes • the prevention, diagnosis and management of high blood pressure • antiplatelet therapy

What was measured: Patients admitted under vascular surgeon with peripheral arterial disease who had statins prescribed on the electronic discharge letter
Data collection end: July 2010
69.91%
Number that met the criteria: 79 / 113
Data collection end: October 2010
75.58%
Number that met the criteria: 65 / 86
Area covered: Local
Source: Agha RA et al (2012) Improving Compliance with Statins in Patients with Peripheral Arterial Disease: A Quality Improvement Study. Annals of Medicine and Surgery. Vol 1 pp30–33
What was measured: Proportion of patients with peripheral arterial disease with a record in the preceding 12 months that aspirin or an alternative anti-platelet is being taken.
Data collection end: July 2015
86.4%
Area covered: England
Source: Health and Social Care Information Centre. Quality Outcomes Framework.

 Return to CG147 Overview